Market Closed -
Other stock markets
|
Pre-market 14:11:11 | |||
129.5 USD | -1.22% | 129.9 | +0.30% |
02:30pm | Merck: positive results for Keytruda in breast cancer | CF |
01:48pm | Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.78% | 328B | |
+38.51% | 727B | |
-6.23% | 354B | |
+1.35% | 277B | |
+14.42% | 243B | |
+7.55% | 205B | |
-6.01% | 203B | |
+6.19% | 164B | |
+0.31% | 164B | |
-0.99% | 122B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. - Shareholder/Analyst Call